- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
Chart Of The Day: Arcellx - Reimagining Cell Therapy
December 08, 2023
Tickers
ACLX
From TalkMarkets
Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November
December 06, 2023
From TalkMarkets
Can Small Cap Biotech Stocks Continue To Run? Let’s Take A Look
December 05, 2023
Tickers
XBI
From TalkMarkets
The Canadian Cannabis Report - Monday, Dec. 4
December 04, 2023
From TalkMarkets
Week In Review: Tang Capital Offers $465 Million For LianBio Plus 80% Of Any Licenses/Divestments
December 02, 2023
From TalkMarkets
From TalkMarkets
Pfizer’s Stock Is Down 44% YTD As Woes Continue
December 01, 2023
From TalkMarkets
The Canadian Cannabis Report - Monday, Nov. 27
November 27, 2023
From TalkMarkets
Biotech And Healthcare Portfolio Playbook For December 2023/24
November 27, 2023
From TalkMarkets
Week In Review: BeiGene Signs $1.3 Billion Deal For Preclinical CDK2 Inhibitor From Boston’s Ensem
November 25, 2023
From TalkMarkets
These Three Biotech Stocks Are Trading At A Discount
November 23, 2023
From TalkMarkets
GH Research Drags Down Psychedelic Drug Stocks Index By 7%
November 23, 2023
From TalkMarkets
Are You A Trader Or Investor: Biotech Momentum Is Picking Up
November 20, 2023
From TalkMarkets
Week In Review: Legend Partners DLL3 CAR-T Candidate With Novartis In $1.2 Billion Deal
November 18, 2023
From TalkMarkets
'Santa Married Goldilocks' - Soft CPI Sparks Big Week Of Buying For Bonds, Stocks, & Gold
November 17, 2023
From TalkMarkets
Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion Deal
November 11, 2023
From TalkMarkets
Psychedelic Compound-Based R&D Stocks Not For The Faint Of Heart
November 11, 2023
From TalkMarkets
Vanda Pharmaceuticals: A Beautiful Head And Shoulders Top
November 09, 2023
Tickers
VNDA
From TalkMarkets
Tickers
LLY
From TalkMarkets
Earnings Review: Bayer To Make Strategic Changes After Q3 Results
November 08, 2023
Tickers
BAYRY
From TalkMarkets
Risk On For Biotech - Time To Trade The Small Caps
November 06, 2023
From TalkMarkets
From TalkMarkets
Week In Review: Hengrui Out-Licenses Next-Gen PARP1 To Merck KGaA For $1.7 Billion
November 04, 2023
From TalkMarkets
Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech
November 01, 2023
From TalkMarkets
From TalkMarkets
Chart Of The Day: Eli Lilly - Big Profits In Big Pharma
October 26, 2023
Tickers
LLY
From TalkMarkets
Bull Of The Day: NeoGenomics
October 24, 2023
From TalkMarkets
From TalkMarkets
Week In Review: China's Biopharmas Announce $2.5 Billion In Deals
October 21, 2023
From TalkMarkets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.